Agape ATP Corporation (NASDAQ:ATPC – Get Free Report) was the target of a large drop in short interest in the month of May. As of May 15th, there was short interest totaling 5,215 shares, a drop of 46.0% from the April 30th total of 9,663 shares. Based on an average trading volume of 67,588 shares, the short-interest ratio is presently 0.1 days. Approximately 0.5% of the company’s shares are short sold.
Analyst Upgrades and Downgrades
A number of equities analysts have recently commented on the stock. Wall Street Zen raised shares of Agape ATP from a “sell” rating to a “hold” rating in a research note on Sunday, April 12th. Weiss Ratings reissued a “sell (e+)” rating on shares of Agape ATP in a research note on Friday, May 22nd. One equities research analyst has rated the stock with a Sell rating, Based on data from MarketBeat, Agape ATP has an average rating of “Sell”.
Check Out Our Latest Stock Analysis on ATPC
Agape ATP Stock Performance
Agape ATP (NASDAQ:ATPC – Get Free Report) last issued its earnings results on Friday, May 15th. The company reported ($0.33) EPS for the quarter. Agape ATP had a negative net margin of 125.89% and a negative return on equity of 8.43%. The business had revenue of $0.27 million during the quarter.
Hedge Funds Weigh In On Agape ATP
A hedge fund recently raised its stake in Agape ATP stock. Citadel Advisors LLC boosted its position in Agape ATP Corporation (NASDAQ:ATPC – Free Report) by 95.7% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 65,130 shares of the company’s stock after buying an additional 31,849 shares during the quarter. Citadel Advisors LLC owned 0.13% of Agape ATP worth $82,000 at the end of the most recent quarter. 0.01% of the stock is owned by institutional investors and hedge funds.
About Agape ATP
Agape ATP Corporation, an investment holding company, supplies health and wellness products and health solution advisory services in Malaysia. It offers four series of programs that consist of various services and products under the ATP Zeta Health Program, ÉNERGÉTIQUE, BEAUNIQUE, and E.A.T.S. names. The company's products include ATP1s Survivor Select that contains various essential nutrients required by the human body to maintain normal metabolism; ATP3 Ionized Cal-Mag, a calcium and magnesium minerals supplement; ATP4 Omega Blend, an oil blend that provides a bio-effective balance of essential fatty acids, omega 3, and omega 6; ATP5 BetaMaxx, a natural immune enhancer; AGN-Vege Fruit Fiber, a nutrition-based formulation for intestines and stomach; AGP1-Iron to improve iron deficiency anemia; and YFA-Young Formula, an anti-aging and youthful maintenance supplement.
Featured Articles
- Five stocks we like better than Agape ATP
- Palantir Stock Faces Technical Pressure Despite Strong AI Growth
- These 3 CLO ETFs Target a Niche Corner of the Fixed-Income Market
- 3 Ways to Play the Data Center Land Grab
- The Smarter Way to Invest in AI Without Taking Extreme Risk
Receive News & Ratings for Agape ATP Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agape ATP and related companies with MarketBeat.com's FREE daily email newsletter.
